Seidman A - Search Results

1

Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.

Polite BN, Cirrincione C, Fleming GF, Berry DA, Seidman A, Muss H, Norton L, Shapiro C, Bakri K, Marcom K, Lake D, Schwartz JH, Hudis C, Winer EP. Polite BN, et al. Among authors: seidman a. J Clin Oncol. 2008 Jun 1;26(16):2659-65. doi: 10.1200/JCO.2007.13.9782. J Clin Oncol. 2008. PMID: 18509177 Free PMC article.

2

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer.

Seidman AD, Hudis CA, Fennelly D, Raptis G, Baselga J, Norton L. Seidman AD, et al. Semin Oncol. 1995 Oct;22(5 Suppl 12):108-16. Semin Oncol. 1995. PMID: 7481852 Review.

3

Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer.

Seidman AD, Norton L, Reichman BS, Crown JP, Yao TJ, Hakes TB, Lebwohl DE, Gilewski TA, Hudis CA, Surbone A, et al. Seidman AD, et al. Oncology. 1994 Oct;51 Suppl 1:33-9. doi: 10.1159/000227414. Oncology. 1994. PMID: 7526308 Clinical Trial.

4

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response.

Seidman AD, Reichman BS, Crown JP, Yao TJ, Currie V, Hakes TB, Hudis CA, Gilewski TA, Baselga J, Forsythe P, et al. Seidman AD, et al. J Clin Oncol. 1995 May;13(5):1152-9. doi: 10.1200/JCO.1995.13.5.1152. J Clin Oncol. 1995. PMID: 7537798 Clinical Trial.

5

Memorial Sloan-Kettering Cancer Center experience with paclitaxel in the treatment of breast cancer: from advanced disease to adjuvant therapy.

Seidman AD, Hudis CA, Norton L. Seidman AD, et al. Semin Oncol. 1995 Aug;22(4 Suppl 8):3-8. Semin Oncol. 1995. PMID: 7543701 Clinical Trial.

6

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.

Seidman AD, Tiersten A, Hudis C, Gollub M, Barrett S, Yao TJ, Lepore J, Gilewski T, Currie V, Crown J, et al. Seidman AD, et al. J Clin Oncol. 1995 Oct;13(10):2575-81. doi: 10.1200/JCO.1995.13.10.2575. J Clin Oncol. 1995. PMID: 7595709 Clinical Trial.

7

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer.

Reichman BS, Seidman AD, Crown JP, Heelan R, Hakes TB, Lebwohl DE, Gilewski TA, Surbone A, Currie V, Hudis CA, et al. Reichman BS, et al. Among authors: seidman ad. J Clin Oncol. 1993 Oct;11(10):1943-51. doi: 10.1200/JCO.1993.11.10.1943. J Clin Oncol. 1993. PMID: 7691998 Clinical Trial.

8

Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.

Foa R, Norton L, Seidman AD. Foa R, et al. Among authors: seidman ad. Int J Clin Lab Res. 1994;24(1):6-14. doi: 10.1007/BF02592403. Int J Clin Lab Res. 1994. PMID: 7910054 Review.

9

Phase II trial of carboplatin and etoposide in metastatic breast cancer.

Crown J, Hakes T, Reichman B, Lebwohl D, Gilewski T, Surbone A, Currie V, Yao TJ, Hudis C, Seidman A, et al. Crown J, et al. Among authors: seidman a. Cancer. 1993 Feb 15;71(4):1254-7. doi: 10.1002/1097-0142(19930215)71:4<1254::aid-cncr2820710414>3.0.co;2-x. Cancer. 1993. PMID: 8435802 Clinical Trial.

10

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.

Hudis CA, Seidman AD, Crown JP, Balmaceda C, Freilich R, Gilewski TA, Hakes TB, Currie V, Lebwohl DE, Baselga J, Raptis G, Gollub M, Robles M, Bruno R, Norton L. Hudis CA, et al. Among authors: seidman ad. J Clin Oncol. 1996 Jan;14(1):58-65. doi: 10.1200/JCO.1996.14.1.58. J Clin Oncol. 1996. PMID: 8558221 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page